Effects of a Flaxseed-Derived Lignan Supplement in Type 2 Diabetic Patients: A Randomized, Double-Blind, Cross-Over Trial
An Pan, Jianqin Sun, Yanqiu Chen et al. · 2007
Read Effects of a Flaxseed-Derived Lignan Supplement in Type 2 Diabetic Patients: A Randomized, Double-Blind, Cross-Over Trial by An Pan, Jianqin Sun, Yanqiu Chen et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001148.txt.
Description
Flaxseed has been shown to improve blood lipids in people, and a flaxseed compound called lignan improved blood sugar control in animals. An Pan and colleagues put the lignan to a human test in a 2007 PLOS ONE article. Their trial involved patients with type 2 diabetes.
The study was randomized, double-blind, and used a cross-over design, so each patient served as their own comparison. It measured the supplement's effects on blood sugar control, lipid profiles, and insulin measures. The paper adds controlled human evidence to a question mostly studied in animals before.
Catalog record
| CREATOR | An Pan, Jianqin Sun, Yanqiu Chen et al. |
|---|---|
| YEAR | 2007 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001148